PL365461A1 - Kompozycje i sposoby pułapkowania i inaktywowaniadrobnoustrojów patogennych oraz plemników - Google Patents

Kompozycje i sposoby pułapkowania i inaktywowaniadrobnoustrojów patogennych oraz plemników

Info

Publication number
PL365461A1
PL365461A1 PL01365461A PL36546101A PL365461A1 PL 365461 A1 PL365461 A1 PL 365461A1 PL 01365461 A PL01365461 A PL 01365461A PL 36546101 A PL36546101 A PL 36546101A PL 365461 A1 PL365461 A1 PL 365461A1
Authority
PL
Poland
Prior art keywords
compositions
composition
risk
antimicrobial
contraceptive
Prior art date
Application number
PL01365461A
Other languages
English (en)
Other versions
PL202918B1 (pl
Inventor
Sanjay Garg
Lourens Jan Dirk Zaneveld
Robert Anthony Anderson Jr.
Donald Paul Waller
Original Assignee
Rush-Presbyterian-St.Luke's Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rush-Presbyterian-St.Luke's Medical Center filed Critical Rush-Presbyterian-St.Luke's Medical Center
Publication of PL365461A1 publication Critical patent/PL365461A1/pl
Publication of PL202918B1 publication Critical patent/PL202918B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL365461A 2000-03-07 2001-03-06 Przeciwbakteryjna i antykoncepcyjna kompozycja oraz jej zastosowanie PL202918B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18757400P 2000-03-07 2000-03-07
PCT/US2001/007042 WO2001066084A2 (en) 2000-03-07 2001-03-06 Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa

Publications (2)

Publication Number Publication Date
PL365461A1 true PL365461A1 (pl) 2005-01-10
PL202918B1 PL202918B1 (pl) 2009-08-31

Family

ID=22689528

Family Applications (1)

Application Number Title Priority Date Filing Date
PL365461A PL202918B1 (pl) 2000-03-07 2001-03-06 Przeciwbakteryjna i antykoncepcyjna kompozycja oraz jej zastosowanie

Country Status (14)

Country Link
US (1) US6706276B2 (pl)
EP (1) EP1263411B1 (pl)
CN (1) CN100488517C (pl)
AT (1) ATE489937T1 (pl)
AU (2) AU2001243431B2 (pl)
BR (1) BRPI0109078B8 (pl)
CA (1) CA2402589C (pl)
DE (1) DE60143566D1 (pl)
ES (1) ES2357474T3 (pl)
HU (1) HU230315B1 (pl)
IL (2) IL151649A0 (pl)
PL (1) PL202918B1 (pl)
RU (1) RU2274442C2 (pl)
WO (1) WO2001066084A2 (pl)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105177B1 (en) * 2000-10-20 2006-09-12 Miller Brewing Company Antimicrobial diapers and wet wipes
KR20040028336A (ko) * 2002-09-30 2004-04-03 김종국 신규한 질내 투여용 항균 온도감응성 겔 조성물
US20040156781A1 (en) * 2002-10-15 2004-08-12 Porter Christopher H. Polymeric materials for site specific delivery to the body
WO2005007150A2 (en) * 2003-07-17 2005-01-27 Bar-Ilan University Method for inhibiting protein synthesis in sperm
TWI347940B (en) * 2003-11-07 2011-09-01 Novartis Ag Methods for synthesizing quinolinone compounds
US7619008B2 (en) 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20060106117A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Compound and method for prevention and/or treatment of vaginal infections
US20060127459A1 (en) * 2004-12-15 2006-06-15 Lei Huang Urogenital infection inhibition
US20060147502A1 (en) * 2004-12-30 2006-07-06 Kimberly-Clark Worldwide, Inc. Methods for controlling microbial pathogens on currency and mail
KR100679924B1 (ko) 2005-02-28 2007-02-08 영남대학교 산학협력단 신규한 클로트리마졸 질 좌제 조성물
US8703198B2 (en) * 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
US20080193428A1 (en) * 2005-04-27 2008-08-14 Shenzhen Phlora Biotechnology Limited Composition and Method for Modulating and Maintaining Vaginal Bacterial Flora and Vaginal Acidity
WO2006124413A2 (en) 2005-05-13 2006-11-23 Novartis Ag Methods for treating drug resistant cancer
US7786176B2 (en) 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
GB2430881B (en) 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
US8666445B2 (en) * 2005-10-25 2014-03-04 Kyocera Corporation Apparatus, system, and method for transmission antenna switching in a portable communication device
BRPI0619370A2 (pt) * 2005-11-29 2011-09-27 Novartis Ag formulações de quinolinonas
US7745158B2 (en) * 2005-12-14 2010-06-29 Kimberly-Clark Worldwide, Inc. Detection of secreted aspartyl proteases from Candida species
RU2329790C1 (ru) * 2006-12-07 2008-07-27 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Лечебно-профилактическое средство, обладающее антибактериальным и спермицидным действием
CN100463675C (zh) * 2007-01-29 2009-02-25 高章圈 一种可溶性缓释外用避孕药
GB0707096D0 (en) 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
WO2008148018A2 (en) * 2007-05-24 2008-12-04 New York Blood Center Inc. Rapidly dispersible vaginal tablet that provides a bioadhesive gel
RU2353395C2 (ru) * 2007-06-14 2009-04-27 Елена Борисовна Иванова Биоцидная композиция на липосомальной основе
RU2527894C2 (ru) 2007-11-27 2014-09-10 Альгифарма ИПР АС Использование альгинатных олигомеров в борьбе с биопленками
DE102008005498A1 (de) * 2008-01-22 2009-07-23 Ma, Te-Lun Haftende, Spermien blockierende Wirkstoffkombination mit kontrazeptiver Wirkung
US20090197946A1 (en) * 2008-01-31 2009-08-06 Joseph Di Bartolomeo Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases
CN101249084B (zh) * 2008-03-18 2011-09-21 上海麟翔生物技术有限公司 可预防性传播疾病的消毒组方
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
US8795717B2 (en) 2009-11-20 2014-08-05 Kimberly-Clark Worldwide, Inc. Tissue products including a temperature change composition containing phase change components within a non-interfering molecular scaffold
CA2764197C (en) 2009-06-03 2017-09-12 Algipharma As Alginate oligomers for use in overcoming multidrug resistance in bacteria
US9181465B2 (en) * 2009-11-20 2015-11-10 Kimberly-Clark Worldwide, Inc. Temperature change compositions and tissue products providing a cooling sensation
US8480852B2 (en) 2009-11-20 2013-07-09 Kimberly-Clark Worldwide, Inc. Cooling substrates with hydrophilic containment layer and method of making
US9539077B1 (en) 2011-12-05 2017-01-10 Daniel A. Dopps Method for alternatively resisting and permitting menstrual flow
CN104487054A (zh) * 2012-06-13 2015-04-01 伊沃菲姆股份有限公司 用于增强避孕杀微生物剂有效性的组合物和方法
CN102784416B (zh) * 2012-08-28 2014-04-02 福州乾正药业有限公司 一种助分娩凝胶
CN104434890A (zh) * 2013-09-24 2015-03-25 上海市计划生育科学研究所 扁桃酸的用途
CN103655457A (zh) * 2013-09-24 2014-03-26 杨莉 用于调节女性阴道pH值的温敏凝胶及其制备方法
WO2015070072A1 (en) * 2013-11-07 2015-05-14 Evofem, Inc. Methods for manufacturing contraceptive microbicides with antiviral properties
MX2016008023A (es) * 2013-12-19 2017-01-13 Evofem Inc Composiciones y metodos para inhibir la inflamacion y las enfermedades utilizando un compuesto antimicrobiano con base en acido alginico.
CN105250280B (zh) 2014-07-14 2020-03-10 诺维科国际控股股份有限公司 包含辛苯聚醇和喹诺里西啶生物碱化合物或其来源的杀微生物组合物
US11419835B2 (en) 2016-10-04 2022-08-23 Evofem, Inc. Method of treatment and prevention of bacterial vaginosis
KR102679493B1 (ko) 2017-01-31 2024-07-01 킴벌리-클라크 월드와이드, 인크. 벤조산 에스테르를 포함하는 항균 조성물 및 이를 이용한 세균 생장 억제 방법
EP3615445A4 (en) * 2017-04-24 2020-12-30 Joshua D. Levine PREVENTIVE PROCEDURES WITH THIXOTROPIC BINGHAM PLASTIC FLUID
IL258017B (en) 2018-03-11 2019-10-31 Aquafit Intimate Ltd Intravaginal device and uses thereof
CN108451895A (zh) * 2018-04-26 2018-08-28 霍尔果斯汉智医药科技有限公司 一种左炔诺孕酮阴道膨胀栓及其制备方法
AU2019359210A1 (en) * 2018-10-09 2021-06-03 Crapaud Bio, Inc. Methods of making and using pH modulating compositions in the reproductive system
US12295923B2 (en) 2018-12-27 2025-05-13 Solventum Intellectual Properties Company Antimicrobial compositions with 1,2-alkanediols
CN109745300B (zh) * 2019-02-02 2023-01-03 沈阳得康医药科技有限公司 不含杀精剂的物理避孕凝胶成膜剂
RU2730021C1 (ru) * 2019-10-08 2020-08-14 Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" Средство местного применения для лечения инфекционных вагинитов
DE102020101110A1 (de) 2020-01-17 2021-07-22 Beuth Hochschule Für Technik Berlin Antimykotische Aktivitäten von Hydrogelen auf Basis von Polysacchariden
EP4084798A1 (en) * 2020-02-21 2022-11-09 Yourchoice Therapeutics, Inc. Niclosamide formulations for use as contraceptive
AU2022323509A1 (en) 2021-08-03 2024-02-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hiv-1 vaccination and samt-247 microbicide to prevent hiv-1 infection
US20250302939A1 (en) 2022-05-10 2025-10-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Vaccine for human t-lymphotropic virus-1
US12570838B2 (en) * 2022-08-23 2026-03-10 Impact Biolife Science, Inc. Antimicrobial plastic
WO2026011214A1 (en) * 2024-07-08 2026-01-15 Liquim Limited Natural-origin bioadhesive, biodegradable, protective microfilm barrier composition and method of use
CN118845630B (zh) * 2024-07-12 2025-08-22 陕西科技大学 一种卡波姆葡萄糖酸铜复合物水凝胶及其制备方法及应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005220A (en) 1973-02-20 1977-01-25 Laboratorios Del Dr. Esteve, S.A. Hemostatic compositions comprising salts of substituted hydroquinone sulfonic acid
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
US5536743A (en) 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
US4999342A (en) * 1988-08-16 1991-03-12 Ortho Pharmaceutical Corporation Long lasting contraceptive suppository composition and methods of use
US5624675A (en) 1989-06-06 1997-04-29 Kelly; Patrick D. Genital lubricants containing zinc salts to reduce risk of HIV infection
US5599551A (en) 1989-06-06 1997-02-04 Kelly; Patrick D. Genital lubricants containing zinc as an anti-viral agent
US5545673A (en) 1989-06-06 1996-08-13 Kelly; Patrick D. Method for reducing risk of infection by sexually transmitted viruses
US5482053A (en) 1989-06-06 1996-01-09 Kelly; Patrick D. Condom lubricants containing zinc as an anti-viral agent
US6017521A (en) 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
US5196452A (en) 1991-01-29 1993-03-23 Genelabs Incorporated Macrocyclic anti-viral compound and method
US5166173A (en) 1991-01-29 1992-11-24 Genelabs Incorporated Method of treating herpes simplex virus infection
US5312837A (en) 1991-01-29 1994-05-17 Genelabs Technologies, Inc. Method of treating viral infections with aryl macrocyclic compounds
US5244652A (en) * 1991-03-22 1993-09-14 E. B. Michaels Research Associates, Inc. Viscous surface active composition
IT1253711B (it) 1991-12-17 1995-08-23 Alfa Wassermann Spa Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
US5308612A (en) 1992-08-12 1994-05-03 Blue Marble Research, Inc. Uses of polystyrenesulfonate and related compounds as inhibitors of transactivating transcription factor (TAT) and as therapeutics for HIV infection and AIDS
US5354558A (en) * 1992-09-10 1994-10-11 Mcneil-Pcc, Inc. Bioerodible contraceptive suppository
ZA942302B (en) * 1993-12-03 1995-09-29 Lafor Lab Ltd Viracidal bactericidal and spermicidal vaginal suppository
EP0939608B1 (en) * 1994-06-29 2006-09-13 Reprotect LLC Device and gel for acidic buffering
US5592949A (en) * 1994-06-29 1997-01-14 Moench; Thomas R. Device for acidic buffering and method for inactivation of pathogens
US5667492A (en) 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
FR2728464B1 (fr) * 1994-12-22 1997-04-30 Innothera Lab Sa Forme galenique unitaire, son procede d'obtention et ses utilisations
US6063773A (en) 1995-09-29 2000-05-16 Polydex Pharmaceuticals Ltd. Cellulose sulfate for use as antimicrobial and contraceptive agent
US5925621A (en) 1995-10-13 1999-07-20 Rush-Presbyterian, St. Luke's Medical Center Method for preventing sexually transmitted diseases
US6028115A (en) 1995-10-13 2000-02-22 Rush-Presbyterian-St. Luke's Medical Center Method for preventing sexually transmitted diseases
US6239182B1 (en) * 1995-10-13 2001-05-29 Rush-Presbyterian-St. Lukes Medical Center Method for preventing sexually transmitted diseases
US5932619A (en) 1995-10-13 1999-08-03 Rush-Presbyterian, St. Luke's Medical Center Method for preventing sexually transmitted diseases
US5741525A (en) 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
NZ332578A (en) * 1996-05-09 2000-06-23 Infectio Recherche Inc Gel formulation containing poloxamer compound for use in the prevention of pathogen induced diseases including HIV and HSV
US5700679A (en) 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
BR9610211A (pt) * 1996-06-12 1999-12-21 Stoa Sa Composições farmacêuticas baseadas em gel tipo gliceril poli(meta)acrilato
RU2102977C1 (ru) * 1996-09-30 1998-01-27 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Суппозитории ректальные и вагинальные, обладающие антимикробным, антивирусным и противовоспалительным действием, и способ их получения
US5819742A (en) 1996-11-06 1998-10-13 Family Health International Vaginal device for preventing conception or the transmission of sexually transmitted diseases, or both
CA2367266A1 (en) * 1999-03-19 2000-09-28 Mingshu Li Gel-microemulsion formulations

Also Published As

Publication number Publication date
CN1431895A (zh) 2003-07-23
CA2402589C (en) 2011-02-01
HUP0301417A2 (hu) 2004-05-28
RU2274442C2 (ru) 2006-04-20
BRPI0109078B1 (pt) 2017-03-14
HU230315B1 (hu) 2016-01-28
BR0109078A (pt) 2003-12-30
CA2402589A1 (en) 2001-09-13
CN100488517C (zh) 2009-05-20
AU2001243431B2 (en) 2006-05-25
AU4343101A (en) 2001-09-17
BRPI0109078B8 (pt) 2021-05-25
WO2001066084A2 (en) 2001-09-13
EP1263411A2 (en) 2002-12-11
RU2002126560A (ru) 2004-03-20
EP1263411B1 (en) 2010-12-01
IL151649A0 (en) 2003-04-10
US20040009223A1 (en) 2004-01-15
IL151649A (en) 2013-08-29
US6706276B2 (en) 2004-03-16
ATE489937T1 (de) 2010-12-15
DE60143566D1 (de) 2011-01-13
ES2357474T3 (es) 2011-04-26
PL202918B1 (pl) 2009-08-31
WO2001066084A3 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
IL151649A0 (en) Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
Huang et al. Substantial decrease of heat-shock protein 90 precedes the decline of sperm motility during cooling of boar spermatozoa
US5545401A (en) Antiviral, spermicidal vaginal gel and foam containing low molecular weight povidone-iodine
Killian et al. Immunocontraception of Florida feral swine with a single‐dose GnRH vaccine
ATE455526T1 (de) Nicht-hormonales vaginales verhütungsmittel
AU2007229268B2 (en) Contraceptive composition
EA200601647A1 (ru) Противовагинитные композиции, содержащие триазол
US7718642B2 (en) AIDS prophylactic lubricating composition
DE59909533D1 (de) Vorrichtung zur besamung von tieren, insbesondere sauen
Dayal et al. Disruption of the upper female reproductive tract epithelium by nonoxynol-9
RU2173142C1 (ru) Вагинальный контрацептив
Kranjčić-Zec et al. The role of parasites and fungi in secondary infertility
US6302108B1 (en) Spermicidal and viricidal compositions
WO2002045706A3 (en) The use of polymers for inactivating pathogens
Short Contraceptives of the future in the light of HIV infection
US5725870A (en) Methods, composites and articles for contraception
US7144921B2 (en) Composition having antibacterial and antifungal properties
US20070141177A1 (en) Method for enhancing fertility
Venere On research: new contraceptive gel prevents pregnancy and STDs
Buchweitz et al. Organ-preserving or ablative treatment?: which endoscopic procedure is sensible for treating tubo-ovarian abscesses?
Bartolome Pharmacological regulation of ovarian function in dairy cows to improve reproductive performance
Walling How effective are popular vaginal spermicides?
Bergeron et al. Microbicidal gel to prevent the transmission of pathogens causing sexually transmitted diseases
UA41022A (uk) Спосіб профілактики і лікування затримання навколоплідних оболонок (посліду) у корів
UA41023A (uk) Спосіб профілактики і лікування затримання посліду у корів